FDA Approves First Single-Dose Generic Treatment for Influenza
press_releaseUnited States·U.S. Food and Drug Administration·Wire Summary
The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
AI Business Impact
How does this affect your business?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.